mechanism of action of glp 1 receptor agonists Glucagon-like peptide agonists: cardiovascular benefits and mechanisms Incretin-based therapies in MASLD/MASH: from

BPC-157 Injection vs Oral Peptide: The Core Pharmacokinetic Difference The central question in the BPC-157 injection vs oral peptide debate is bioavailability the fraction of the administered dose that reaches systemic circulation intact and at therapeutically relevant concentrations

As early as 1921, Hopkins first discovered glutathione, and divided glutathione into reduced (GSH) and oxidized (GSSG) types

Demothoxycurcumin as a curcumin analogue with anticancer, antimicrobial, anti-inflammatory, and neuroprotective activities: micro and nanosystems

Could type 2 diabetes be reserved using surgery? New scientist, 2007;2619: 11-13